Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT01650610
Other study ID # USPNEC001
Secondary ID
Status Recruiting
Phase N/A
First received July 19, 2012
Last updated November 6, 2012
Start date July 2012
Est. completion date July 2013

Study information

Verified date November 2012
Source University of Sao Paulo
Contact Siqueira, Ms
Phone 55-11-25788177
Email parkinson@parkinson.org.br
Is FDA regulated No
Health authority Brazil: National Committee of Ethics in Research
Study type Interventional

Clinical Trial Summary

The aim of this study is the development and implementation of a new protocol of a physical therapy training, based on a gait training associated with executive tasks, for treatment of individuals with Parkinson's Disease.

The hypothesis is that this group of patients who will carry out training of this study protocol will show improvement in measured parameters (functionality of gait and cognitive ability), which allows this protocol to be improved and published as a proposal of physiotherapeutic treatment.


Description:

The aim of this study is the development and implementation of a new protocol of physical therapy training, based on a gait training associated with executive tasks for treatment of individuals with Parkinson's Disease.

The proposed motor training consists of 30 minutes of global exercises that involves stretching, muscle strengthen and axial mobility exercises, and after this, 30 minutes of gait training in a dual-task condition, associated with distracting tasks that require handling of the main executive functions.

It will be an open label study, non randomized, where 30 patients with PD in stages 1 to 3 on Hoehn & Yahr scale will participate in the study, to be held in Brazil Parkinson Association. The training will consist of 10 sessions, two times per week for five weeks.

The executive tasks concomitant with gait training cover the following executive functions: volition, self-awareness, planning, response inhibition, response monitoring and attention.

The main outcome measures are: (1) Dynamic Gait Index (DGI), (2) Montreal Cognitive Assessment (MoCA), (3) Trail Making Test A and B, (4) Unified Parkinson's Disease Rating Scale (UPDRS) and (5) Falls Efficacy Scale (FES).


Recruitment information / eligibility

Status Recruiting
Enrollment 30
Est. completion date July 2013
Est. primary completion date February 2013
Accepts healthy volunteers No
Gender Both
Age group 50 Years to 85 Years
Eligibility Inclusion Criteria:

- Diagnosis of Idiopathic PD performed by a neurologist specialist in movement disorders;

- In use of dopaminergic medication;

- Disease severity of 1 to 3 according to Hoehn & Yahr scale;

- Absence of other neurological disorders or co-morbidities that may affect gait;

- Absence of dementia (score above 24 on the Mini Mental State Examination - MMSE);

- Vision and hearing adequate or corrected to normal;

- Ability to walk independently;

- Absence of prolonged off state;

- Age 50 to 85 years.

Exclusion Criteria:

- Biomechanical alterations (other pathologies) that could compromise the completion of training;

- Presence of depression, detected by the Geriatric Depression Scale (GDS-15);

- Presence of any neurological, auditory or visual deficit that could compromise distracting task performance during gait training;

- Any changes in drug treatment for PD.

Study Design

Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Behavioral:
Gait training executive functions tasks
The training will consist of 10 sessions, two times per week for five weeks, and consists of 30 minutes of global exercises that involves stretching, muscle strengthen and axial mobility exercises, and another 30 minutes of gait training in a dual-task condition associated with distracting tasks that require handling of the main executive functions: volition, self-awareness, planning, response inhibition, response monitoring and attention.

Locations

Country Name City State
Brazil Brazil Parkinson Association São Paulo

Sponsors (2)

Lead Sponsor Collaborator
University of Sao Paulo Coordination for the Improvement of Higher Education Personnel

Country where clinical trial is conducted

Brazil, 

Outcome

Type Measure Description Time frame Safety issue
Primary Dynamic Gait Index The scale assesses the ability to adapt the gait during motor tasks with different demands. 02/2013 (Up to seven months) No
Secondary Montreal Cognitive Assessment This scale was developed in order to detect mild degrees of cognitive impairment. The instrument assesses different cognitive domains such as attention and concentration, executive functions, memory, language, visuo-constructive skills, calculations, and orientation. 02/2013 (Up to seven months) No
See also
  Status Clinical Trial Phase
Completed NCT01736891 - Clinical Trial of Rasagiline in Levodopa-Treated Parkinson's Disease Patients With Motor Fluctuations Phase 3
Recruiting NCT03866603 - Rostock International Parkinson's Disease Study (ROPAD)
Completed NCT00902941 - Olfaction in Patients With Parkinson's Disease Following Treatment With Rasagiline Phase 4
Completed NCT03103919 - Study to Evaluate the Impact of Using Wearable Devices in Addition to Standard Clinical Practice on Parkinson´s Subject Symptoms Management Phase 4
Recruiting NCT01650623 - Gait Training With Executive Functions Tasks in Subjects With Parkinson´s Disease: A Randomised Controlled Trial N/A
Recruiting NCT02578849 - Common Noradrenergic Mechanisms in Parkinson´s Disease and L-DOPA Induced Dyskinesia N/A
Completed NCT01003535 - Quantification of Cerebral Cholinergic Function in Parkinson´s Disease by Means of Nuclear Medicine Methods Phase 1
Completed NCT01038310 - Prognostic Value of FP-CIT-SPECT in Parkinson´s Disease
Terminated NCT00562198 - PET-Study: Effects of Single Doses of Stalevo and Levodopa/Carbidopa on Striatal 11C-Raclopride Binding Phase 2
Completed NCT01580787 - Functional Improvement in Patients With Parkinson's Disease After Training in Real or Virtual Environment N/A
Completed NCT00964652 - Treadmill Training With Additional Body Load: Effects on Gait of Subjects With Parkinson´s Disease N/A
Completed NCT01960985 - Balance Training in Parkinson's Disease Using Cues Phase 3
Completed NCT01391741 - The Effect of High-Volume Walking With Visual Cues (VC) in Parkinson´s Disease (PD) Phase 3